Dr. Shepherd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
801 W I 20
Ste 1
Arlington, TX 76017Phone+1 817-784-8268Fax+1 817-417-1150
Summary
- Dr. David Shepherd is an urologist in Arlington, TX and is affiliated with multiple hospitals in the area, including USMD Hospital at Arlington, Texas Health Arlington Memorial Hospital, and Texas Health Harris Methodist Hospital Fort Worth. He received his medical degree from Washington University School of Medicine in St. Louis and has been in practice 26 years. He is experienced in urologic oncology and minimally invasive urologic surgery.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Urology, 1993 - 1997
- Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 1991 - 1993
- Washington University in St. Louis School of MedicineClass of 1991
Certifications & Licensure
- TX State Medical License 1997 - 2026
- American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 209 citationsEffects of Blocking Platelet-Derived Growth Factor-Receptor Signaling in a Mouse Model of Experimental Prostate Cancer Bone MetastasesHisanori Uehara, Sun Jin Kim, Takashi Karashima, David L. Shepherd, Dominic Fan
Journal of the National Cancer Institute. 2003-03-19 - 122 citationsBlockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer ...Sun Jin Kim, Hisanori Uehara, Takashi Karashima, David L. Shepherd, Jerald J. Killion
Clinical Cancer Research. 2003-03-01 - 44 citationsInhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-α-2b and docetaxelSamuel F. Huang, Sun Jin Kim, Anh Tuyet Lee, Takashi Karashima, Cora Bucana
Cancer Research. 2002-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: